Literature DB >> 33628862

Differential Expression Profiles of Mitogenome Associated MicroRNAs Among Colorectal Adenomatous Polyps.

LaShanale Wallace1, Karen Aikhionbare2, Saswati Banerjee3, Katie Peagler1, Mareena Pitts1, Xuebiao Yao3, Felix Aikhionbare1.   

Abstract

Colorectal tumors are mostly of epithelial origin and represent a wide spectrum of neoplasms. About 97% of colorectal cancer originating from benign lesions of adenomatous polyps are adenocarcinomas. Reactive oxygen species (ROS) generating from mitochondrial DNA (mtDNA) mutations and microRNAs (miRNAs) are associated with oncogene and tumor suppressor genes regulation which are known to parallel the tissue abnormalities involved with tumorigenesis such as colorectal adenoma to adenocarcinoma. However, the differential expression patterns of mitochondrial associated microRNAs (referred as MitomiRs) among colorectal adenomatous polyps progression is yet to be determined. Thus, the aim of this study was to determine the differential expressions profiles of MitomiRs (miR-24, miR-181, miR-210, miR-21 and miR378) in patients with colorectal adenomatous polyps tissues in correlation with clinicopathological tumor architectures of tubular, tubulovillous, villous adenomas and adenocarcinomas. Isolation of mitochondria RNA from colorectal adenomatous polyps, adenocarcinomas, and normal adjacent tissue samples was performed and assessed for mitochondrial associated miRNAs expression differences using quantitative reverse transcription PCR. Data from this study demonstrates that mitochondria genome expression of mitomiRNAs; miR-24, miR-181, miR-210, miR-21 and miR-378 in colorectal tissue samples varies among the adenomatous polyps. Expression of mitomiRNAs 24, 181, 210 and 378 progressively increased from the precancerous of adenomatous polyps to adenocarcinoma. In addition, miR-210 and miR-181 expression increased 3 folds in villous adenomas and greater than 3 folds increased in miR378 in adenocarcinoma (p < 0.005) when compared to tubular adenoma. Meanwhile, miR-21 increased progressively in adenoma tissues but decreased almost 2.5 folds in adenocarcinomas when compared to villous adenoma tissues (p < 0.001). These results suggest mitomiRs may regulate important mitochondrial functional pathways leading to a more favorable environment for transformation or progression of colorectal adenomatous polyps into adenocarcinomas.

Entities:  

Keywords:  CRC Tissues; Colorectal Adenomas; Mitochondrial microRNA (Denoted: mitomiRNAs); Reactive Oxygen Species

Year:  2021        PMID: 33628862      PMCID: PMC7899164     

Source DB:  PubMed          Journal:  Cancer Res J (N Y N Y)        ISSN: 2330-8192


  51 in total

Review 1.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

2.  miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells.

Authors:  Sivasubramani Thulasingam; Chandirasegaran Massilamany; Arunakumar Gangaplara; Hongjiu Dai; Shahlo Yarbaeva; Sakthivel Subramaniam; Jean-Jack Riethoven; James Eudy; Marjorie Lou; Jay Reddy
Journal:  Mol Cell Biochem       Date:  2011-02-25       Impact factor: 3.396

3.  MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).

Authors:  Defang Sun; Feng Yu; Yutao Ma; Ran Zhao; Xi Chen; Jie Zhu; Chen-Yu Zhang; Jiangning Chen; Junfeng Zhang
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

4.  Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients.

Authors:  Nele Boeckx; Ken Op de Beeck; Matthias Beyens; Vanessa Deschoolmeester; Christophe Hermans; Peggy De Clercq; Sonia Garrigou; Corinne Normand; Els Monsaert; Konstantinos Papadimitriou; Pierre Laurent-Puig; Patrick Pauwels; Guy Van Camp; Valerie Taly; Marc Peeters
Journal:  Clin Colorectal Cancer       Date:  2018-02-22       Impact factor: 4.481

Review 5.  The role of microRNAs in mitochondria in cancer.

Authors:  Julie Bienertova-Vasku; Jiri Sana; Ondrej Slaby
Journal:  Cancer Lett       Date:  2013-05-09       Impact factor: 8.679

6.  microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.

Authors:  Aditya Parikh; Christine Lee; Peronne Joseph; Sergio Marchini; Alessia Baccarini; Valentin Kolev; Chiara Romualdi; Robert Fruscio; Hardik Shah; Feng Wang; Gavriel Mullokandov; David Fishman; Maurizio D'Incalci; Jamal Rahaman; Tamara Kalir; Raymond W Redline; Brian D Brown; Goutham Narla; Analisa DiFeo
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 7.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

Review 8.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.

Authors:  Prashanth Rawla; Tagore Sunkara; Adam Barsouk
Journal:  Prz Gastroenterol       Date:  2019-01-06

9.  Interplay between Reactive oxygen Species and MicroRNAs in Cancer.

Authors:  Jun He; Bing-Hua Jiang
Journal:  Curr Pharmacol Rep       Date:  2016-02-09

Review 10.  MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions.

Authors:  Caterina Catalanotto; Carlo Cogoni; Giuseppe Zardo
Journal:  Int J Mol Sci       Date:  2016-10-13       Impact factor: 5.923

View more
  2 in total

Review 1.  Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.

Authors:  Pieterjan Ginckels; Paul Holvoet
Journal:  Yale J Biol Med       Date:  2022-03-31

Review 2.  Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.

Authors:  Alexandra Wagner; Helena Kosnacova; Miroslav Chovanec; Dana Jurkovicova
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.